Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

NCT06285539 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06285539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06285539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Recruiting
Start date
March 12, 2024
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

behcet's disease, idiopathic inflammatory myopathies, igg4-related disease